Legacy Bridge LLC Grows Stake in Danaher Co. (DHR)

Legacy Bridge LLC raised its position in Danaher Co. (NYSE:DHR) by 2.9% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 4,224 shares of the conglomerate’s stock after buying an additional 120 shares during the period. Legacy Bridge LLC’s holdings in Danaher were worth $558,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in DHR. Nicolet Bankshares Inc. raised its stake in shares of Danaher by 11.3% in the 1st quarter. Nicolet Bankshares Inc. now owns 5,797 shares of the conglomerate’s stock valued at $765,000 after purchasing an additional 589 shares during the period. SPC Financial Inc. acquired a new stake in shares of Danaher in the first quarter valued at about $238,000. Palmer Knight Co increased its position in shares of Danaher by 2.9% in the first quarter. Palmer Knight Co now owns 46,586 shares of the conglomerate’s stock valued at $6,150,000 after acquiring an additional 1,334 shares during the last quarter. K.J. Harrison & Partners Inc grew its holdings in Danaher by 183.3% during the first quarter. K.J. Harrison & Partners Inc now owns 17,000 shares of the conglomerate’s stock worth $2,244,000 after purchasing an additional 11,000 shares during the period. Finally, Brightworth bought a new position in Danaher during the first quarter worth about $220,000. Hedge funds and other institutional investors own 76.98% of the company’s stock.

NYSE DHR traded up $1.53 on Wednesday, reaching $131.74. The company had a trading volume of 1,899,315 shares, compared to its average volume of 2,820,221. The company has a market capitalization of $93.86 billion, a price-to-earnings ratio of 29.15, a PEG ratio of 2.53 and a beta of 1.02. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $134.67. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.06. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a return on equity of 11.61% and a net margin of 12.04%. Danaher’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.99 earnings per share. Research analysts expect that Danaher Co. will post 4.77 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 dividend on an annualized basis and a yield of 0.52%. Danaher’s dividend payout ratio (DPR) is currently 15.04%.

A number of equities analysts recently commented on DHR shares. Janney Montgomery Scott upgraded Danaher from a “neutral” rating to a “buy” rating in a report on Monday, February 25th. UBS Group boosted their price objective on Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Deutsche Bank boosted their price objective on Danaher to $130.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Jefferies Financial Group boosted their price objective on Danaher to $140.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Finally, Needham & Company LLC restated a “buy” rating and set a $138.00 price objective (up previously from $114.00) on shares of Danaher in a report on Thursday, February 28th. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $131.75.

In related news, Director Alan G. Spoon sold 1,913 shares of the company’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the sale, the director now owns 86,863 shares in the company, valued at approximately $11,250,495.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Donald J. Ehrlich sold 5,000 shares of the company’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $132.95, for a total transaction of $664,750.00. Following the completion of the sale, the director now owns 100,603 shares in the company, valued at approximately $13,375,168.85. The disclosure for this sale can be found here. Insiders have sold 462,566 shares of company stock worth $59,987,905 in the last ninety days. Insiders own 11.40% of the company’s stock.

WARNING: This report was posted by Sundance Herald and is the property of of Sundance Herald. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://sundanceherald.com/2019/05/22/legacy-bridge-llc-has-558000-holdings-in-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: What is a Swap?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply